MAPT and Alzheimer disease: Overall, tau sequence analysis data in combination with the presented biological functional analysis, strongly suggest that the unique characteristics of the epitope of DC8E8 antibody determine its therapeutic mode of action as the ability to effectively block tau beta-structure formation and AD tau neuronal internalization by masking HSPG recognition sites via steric hindrance (Fig. 8 a, b).